• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶瘤呼肠孤病毒可有效靶向乳腺癌干细胞。

Oncolytic reovirus effectively targets breast cancer stem cells.

作者信息

Marcato Paola, Dean Cheryl A, Giacomantonio Carman A, Lee Patrick W K

机构信息

Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

出版信息

Mol Ther. 2009 Jun;17(6):972-9. doi: 10.1038/mt.2009.58. Epub 2009 Mar 17.

DOI:10.1038/mt.2009.58
PMID:19293772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2835173/
Abstract

Recent evidence suggests that cancer stem cells (CSCs) play an important role in cancer, as these cells possess enhanced tumor-forming capabilities and are resistant to current anticancer therapies. Hence, novel cancer therapies will need to be tested for both tumor regression and CSC targeting. Herein we show that oncolytic reovirus that induces regression of human breast cancer primary tumor samples xenografted in immunocompromised mice also effectively targets and kills CSCs in these tumors. CSCs were identified based on CD24(-)CD44(+) cell surface expression and overexpression of aldehyde dehydrogenase. Upon reovirus treatment, the CSC population was reduced at the same rate as non-CSCs within the tumor. Immunofluorescence of breast tumor tissue samples from the reovirus- and mock-treated mice confirmed that both CSCs and non-CSCs were infectible by reovirus, and terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling (TUNEL) assay showed that both populations died by apoptosis. Ras, which has been shown to mediate reovirus oncolysis, was found to be present at similar levels in all cell types, and this is consistent with their comparable sensitivity to reovirus. These experiments indicate that oncolytic reovirus has the potential to induce tumor regression in breast cancer patients. More important, the CSC population was equally reduced and was as susceptible to reovirus treatment as the non-CSC population.

摘要

最近的证据表明,癌症干细胞(CSCs)在癌症中起着重要作用,因为这些细胞具有更强的肿瘤形成能力,并且对当前的抗癌疗法具有抗性。因此,新的癌症疗法需要同时针对肿瘤消退和癌症干细胞进行测试。在此我们表明,溶瘤呼肠孤病毒可诱导移植到免疫缺陷小鼠体内的人乳腺癌原发肿瘤样本消退,并且还能有效靶向并杀死这些肿瘤中的癌症干细胞。基于CD24(-)CD44(+)细胞表面表达和醛脱氢酶的过表达来鉴定癌症干细胞。经呼肠孤病毒治疗后,肿瘤内癌症干细胞群体与非癌症干细胞群体以相同的速率减少。来自经呼肠孤病毒处理和模拟处理的小鼠的乳腺肿瘤组织样本的免疫荧光证实,癌症干细胞和非癌症干细胞均可被呼肠孤病毒感染,末端脱氧核苷酸转移酶生物素-dUTP缺口末端标记(TUNEL)分析表明,这两个群体均通过凋亡死亡。已证明可介导呼肠孤病毒溶瘤作用的Ras在所有细胞类型中的水平相似,这与它们对呼肠孤病毒的敏感性相当是一致的。这些实验表明,溶瘤呼肠孤病毒有潜力在乳腺癌患者中诱导肿瘤消退。更重要的是,癌症干细胞群体同样减少,并且与非癌症干细胞群体一样对呼肠孤病毒治疗敏感。

相似文献

1
Oncolytic reovirus effectively targets breast cancer stem cells.溶瘤呼肠孤病毒可有效靶向乳腺癌干细胞。
Mol Ther. 2009 Jun;17(6):972-9. doi: 10.1038/mt.2009.58. Epub 2009 Mar 17.
2
Targeting pediatric cancer stem cells with oncolytic virotherapy.用溶瘤病毒疗法靶向小儿癌干细胞。
Pediatr Res. 2012 Apr;71(4 Pt 2):500-10. doi: 10.1038/pr.2011.58. Epub 2012 Feb 15.
3
Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells.溶瘤痘苗病毒 GLV-1h68 株在人类乳腺癌干细胞中的复制能力较乳腺癌细胞增强。
J Transl Med. 2012 Aug 17;10:167. doi: 10.1186/1479-5876-10-167.
4
Enhanced Killing of Triple-Negative Breast Cancer Cells by Reassortant Reovirus and Topoisomerase Inhibitors.重配呼肠孤病毒与拓扑异构酶抑制剂增强三阴性乳腺癌细胞的杀伤作用。
J Virol. 2019 Nov 13;93(23). doi: 10.1128/JVI.01411-19. Print 2019 Dec 1.
5
Exploring host factors that impact reovirus replication, dissemination, and reovirus-induced cell death in cancer versus normal cells in culture.探索影响呼肠孤病毒在培养的癌细胞与正常细胞中复制、传播及呼肠孤病毒诱导的细胞死亡的宿主因素。
Methods Mol Biol. 2012;797:163-76. doi: 10.1007/978-1-61779-340-0_12.
6
Noncanonical Cell Death Induction by Reassortant Reovirus.重配型呼肠孤病毒诱导非典型细胞死亡。
J Virol. 2020 Oct 27;94(22). doi: 10.1128/JVI.01613-20.
7
Mesenchymal stem cells loaded with oncolytic reovirus enhances antitumor activity in mice models of colorectal cancer.负载溶瘤呼肠孤病毒的间充质干细胞增强结直肠癌小鼠模型的抗肿瘤活性。
Biochem Pharmacol. 2021 Aug;190:114644. doi: 10.1016/j.bcp.2021.114644. Epub 2021 Jun 4.
8
Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus.先天免疫缺陷使乳腺癌起始细胞对溶瘤腺病毒具有易感性。
PLoS One. 2010 Nov 5;5(11):e13859. doi: 10.1371/journal.pone.0013859.
9
Efficacy of oncolytic reovirus against human breast cancer cells.溶瘤呼肠孤病毒对人乳腺癌细胞的疗效。
Oncol Rep. 2008 Jun;19(6):1395-8.
10
Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants.利用下一代呼肠孤病毒变体提高呼肠孤病毒溶瘤效力和特异性的潜力。
Viruses. 2015 Dec 1;7(12):6251-78. doi: 10.3390/v7122936.

引用本文的文献

1
Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities.癌症干细胞与免疫疗法的关联:关键见解、挑战及潜在治疗机遇
Cancers (Basel). 2025 Jun 23;17(13):2100. doi: 10.3390/cancers17132100.
2
Harnessing Oncolytic Viruses for Targeted Therapy in Triple-Negative Breast Cancer.利用溶瘤病毒进行三阴性乳腺癌的靶向治疗
Int J Med Sci. 2025 Apr 13;22(9):2186-2207. doi: 10.7150/ijms.105683. eCollection 2025.
3
Genetic advancements in breast cancer treatment: a review.乳腺癌治疗中的遗传学进展:综述
Discov Oncol. 2025 Feb 7;16(1):127. doi: 10.1007/s12672-025-01884-x.
4
Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies.靶向乳腺癌干细胞(BCSCs)的最新进展:治疗策略和新兴疗法的描述性综述。
Med Oncol. 2024 Apr 9;41(5):112. doi: 10.1007/s12032-024-02347-z.
5
The role of oncolytic virotherapy and viral oncogenes in the cancer stem cells: a review of virus in cancer stem cells.溶瘤病毒疗法及病毒癌基因在癌症干细胞中的作用:癌症干细胞中的病毒综述
Cancer Cell Int. 2023 Oct 25;23(1):250. doi: 10.1186/s12935-023-03099-y.
6
Update on immune-based therapy strategies targeting cancer stem cells.针对癌症干细胞的免疫治疗策略的最新进展。
Cancer Med. 2023 Sep;12(18):18960-18980. doi: 10.1002/cam4.6520. Epub 2023 Sep 12.
7
Modulation of Reoviral Cytolysis (II): Cellular Stemness.病毒溶细胞性的调节(二):细胞干性。
Viruses. 2023 Jun 29;15(7):1473. doi: 10.3390/v15071473.
8
Oncolytic viruses: A novel treatment strategy for breast cancer.溶瘤病毒:一种治疗乳腺癌的新策略。
Genes Dis. 2021 Dec 16;10(2):430-446. doi: 10.1016/j.gendis.2021.11.011. eCollection 2023 Mar.
9
Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment.肿瘤免疫微环境中癌细胞与免疫细胞的串扰:潜在的治疗靶点。
Mol Cancer. 2023 Feb 21;22(1):38. doi: 10.1186/s12943-023-01748-4.
10
Oncolytic viruses for triple negative breast cancer and beyond.用于三阴性乳腺癌及其他癌症的溶瘤病毒
Biomark Res. 2021 Sep 25;9(1):71. doi: 10.1186/s40364-021-00318-4.

本文引用的文献

1
Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.乙醛脱氢酶可区分CD133肝癌干细胞群体。
Mol Cancer Res. 2008 Jul;6(7):1146-53. doi: 10.1158/1541-7786.MCR-08-0035.
2
Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy.化疗后,结直肠癌干细胞在异种移植肿瘤中富集。
PLoS One. 2008 Jun 18;3(6):e2428. doi: 10.1371/journal.pone.0002428.
3
Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis.适者生存:癌症干细胞在治疗抗性和血管生成中的作用
J Clin Oncol. 2008 Jun 10;26(17):2839-45. doi: 10.1200/JCO.2007.15.1829.
4
Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration.细胞内ABC转运蛋白A3通过溶酶体药物隔离赋予白血病细胞多药耐药性。
Leukemia. 2008 Aug;22(8):1576-86. doi: 10.1038/leu.2008.103. Epub 2008 May 8.
5
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.醛脱氢酶1(ALDH1)是正常和恶性人乳腺干细胞的标志物,也是临床预后不良的预测指标。
Cell Stem Cell. 2007 Nov;1(5):555-67. doi: 10.1016/j.stem.2007.08.014.
6
Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.结肠癌干细胞通过产生白细胞介素-4来控制肿瘤生长并抵抗细胞死亡。
Cell Stem Cell. 2007 Oct 11;1(4):389-402. doi: 10.1016/j.stem.2007.08.001.
7
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.不同的癌症干细胞群体决定了人类胰腺癌的肿瘤生长和转移活性。
Cell Stem Cell. 2007 Sep 13;1(3):313-23. doi: 10.1016/j.stem.2007.06.002.
8
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.CD133+肝癌癌干细胞通过优先表达Akt/PKB存活途径赋予化疗抗性。
Oncogene. 2008 Mar 13;27(12):1749-58. doi: 10.1038/sj.onc.1210811. Epub 2007 Sep 24.
9
Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/low cells.
Mol Ther. 2007 Dec;15(12):2088-93. doi: 10.1038/sj.mt.6300300. Epub 2007 Sep 11.
10
Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release.Ras转化通过增强病毒脱壳、颗粒感染性和凋亡依赖性释放来介导呼肠孤病毒的溶瘤作用。
Mol Ther. 2007 Aug;15(8):1522-30. doi: 10.1038/sj.mt.6300179. Epub 2007 Apr 24.